Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Overexpression of key complement regulators in glioblastoma.

PloS one·2026

Same author

Microstructure imaging in patients undergoing evaluation for epilepsy surgery or low-grade glioma: Clinical utility of a novel diffusion MRI method.

Epilepsia open·2026

Same author

Tumour acidosis remodels the glycocalyx to control lipid scavenging and ferroptosis.

Nature cell biology·2026

Same author

GSPT1-specific protein degradation is effective in preclinical models of chemoresistant MYCN-amplified neuroblastoma.

Journal of experimental & clinical cancer research : CR·2026

Same author

Nationwide registry-linked retrospective cohort study of Ganglioglioma in children and adults: Long-term follow-up of anti-seizure medication and mortality.

Seizure·2026

Same author

Noninvasive MGMT-promotor methylation prediction in high grade gliomas using conventional MRI and deep learning-based segmentations.

Frontiers in neuroscience·2026

Same journal

Neoadjuvant and adjuvant therapy in uveal melanoma: toward systemic control of a systemic disease.

Cancer treatment reviews·2026

Same journal

Antiangiogenic therapies in gastric cancer: future directions for 2026 and beyond: an UNICANCER gastrointestinal group (UCGI) perspective.

Cancer treatment reviews·2026

Same journal

Treatment of breast cancer brain metastases in the era of novel drugs.

Cancer treatment reviews·2026

Same journal

Standardization of objectives and response criteria for neoadjuvant immunotherapy in resectable squamous cell carcinoma of the head and neck.

Cancer treatment reviews·2026

Same journal

Precision targeting of CLDN18.2: A new therapeutic paradigm for gastric cancer.

Cancer treatment reviews·2026

Same journal

Beyond body surface area: CT-derived body composition as a predictor of chemotherapy toxicity and survival in pancreatic ductal adenocarcinoma: a systematic review.

Cancer treatment reviews·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 20, 2026

Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds

Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds

Published on: July 16, 2018

Stem cell-based therapy for malignant glioma.

Daniel Bexell¹, Andreas Svensson, Johan Bengzon

¹Lund Stem Cell Center, BMC B10, Lund University, Lund, Sweden; Molecular Medicine, Center for Molecular Pathology, Lund University, Skåne University Hospital, Malmö, Sweden. daniel.bexell@med.lu.se

Cancer Treatment Reviews

|July 17, 2012

Summary

This summary is machine-generated.

Stem cells show promise for malignant glioma gene therapy by targeting tumors. However, challenges like immunosuppression and tumor promotion must be addressed for clinical translation.

More Related Videos

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens

Published on: July 29, 2011

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

Related Experiment Videos

Last Updated: May 20, 2026

Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds

Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds

Published on: July 16, 2018

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens

Published on: July 29, 2011

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

Area of Science:

Oncology
Stem Cell Biology
Gene Therapy

Background:

Stem cells are explored as tumor-tropic vectors for gene delivery to solid tumors.
Malignant gliomas are aggressive brain tumors with limited treatment options.

Purpose of the Study:

To review the potential of stem cells, specifically neural stem cells and multipotent mesenchymal stromal cells, as cellular vector systems for gene therapy in malignant gliomas.
To discuss the possibilities and challenges of translating experimental findings into clinical applications for glioma treatment.

Main Methods:

Review of existing literature on stem cell-based gene therapy for gliomas.
Analysis of stem cell tropism towards gliomas, driven by tumor-derived factors.
Evaluation of therapeutic effects in experimental glioma models.

Main Results:

Stem cells are attracted to invasive gliomas by tumor-derived substances and inflammation.
Engineered stem cells producing anti-tumor agents demonstrate significant therapeutic effects in preclinical glioma models.
Potential risks include immunosuppression, contribution to pro-tumourigenic stroma, and malignant transformation of stem cells.

Conclusions:

Stem cell-based gene therapy holds promise for malignant gliomas but faces significant hurdles.
Further research is needed to identify optimal stem cell types and therapeutic genes for clinical efficacy.
Translating experimental successes into effective clinical treatments requires addressing safety and efficacy concerns.